A 2006 Phase I trial of CJC-1295 reported no serious adverse events across a small number of subjects, but it was a safety study, not an outcomes trial, and there are no large trials showing it does what enthusiasts hope
10/5mg 8 wks on / 8 wks off Combined GHRH and GHRP for synergistic growth hormone release, lean mass, and visceral fat reduction
BPC-157 is the name commonly applied to a synthetic pentadecapeptide
Dinh Tran helps patients combat fatigue, mental fog, and a slowed metabolism with precisely targeted Vitamin B12 therapy
Nanoparticle delivery: Emerging research has explored loading KPV into colonic-targeted nanoparticles for enhanced delivery to the most inflamed mucosal tissue
A spokesperson for the Department of Health and Human Services pushed back on criticism about potential conflicts of interest and said all underwent the standard ethics and vetting process